Introduction: Receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), expressed on the surface of, or secreted by osteoblasts, respectively, are essential factors for facilitating osteoclast formation. In contrast to the activation processes for osteoclast formation, inhibitory mechanisms for it have been poorly understood. Here we demonstrate that inhibitory immunoglobulin-like receptors recruiting Src homology 2 domain-containing tyrosine phosphatase 1 (SHP-1) are expressed on osteoclast precursor cells like other myeloid cells, and that they play regulatory role in the development of osteoclasts. We identified cell-surface expression of paired immunoglobulin-like receptor (PIR)-B and three isoforms of leukocyte immunoglobulin-like receptor (LILR)B on cultured osteoclast precursor cells of mouse and human origin, respectively, and showed that these immunoreceptor tyrosine-based inhibitory motif (ITIM)-harboring inhibitory receptors constitutively recruit SHP-1 in the presence of RANKL and M-CSF and suppress osteoclast development in vitro. Fluorescence energy transfer analyses have suggested that the constitutive binding of either murine PIR-B or its human ortholog LILRB1 to MHC class I molecules on the same cell surface can explain one of the mechanisms for the developmental regulation. These results provide the first evidence for the regulation of osteoclast formation by the cell-surface, ITIM-harboring immunoglobulin-like receptors. Modulation of these regulatory receptors may provide a novel way to control various skeletal system disorders and inflammatory arthritis.
lows: E = 1 -I(DA) / I(D), where I(DA) indicates the fluorescence intensity of prebleach donor cells and I(D) indicates the fluorescence intensity of post-bleach donor cells. E > 0.05 was defined as the threshold level for substantial transfer efficiency.
Results: We cultured bone marrow cells from B6 and PIR-B deficient mice in the presence of M-CSF and RANKL and compared the osteoclastogenesis. MOC development was significantly accelerated in PIR-B deficient cells in the presence of either lower (10 ng/ml) or higher (100 ng/ml) concentration of RANKL. The resorption pit area produced on calcium phosphate matrices was also larger in the culture of PIR-B-deficient MOCs than PIR-B-sufficient B6 mice, indicating that PIR-B deletion may lead to accelerated bone resorption. These analyses indicate that murine osteoclastogenesis in the presence of RANKL and M-CSF in vitro is also negatively regulated by PIR-B.
Flow cytometric analyses revealed that LILRB1, B3 and B4, but not LILRB2, were distinctly expressed on the surface of POCs, suggesting any inhibitory role of these receptors. Especially, LILRB4 expression on POCs was much higher than other myeloid lineage cells. PIR-B protein was abundantly expressed on POCs as well as on macrophages, but not on osteoblasts. Immunoblot analyses indicated that LILRB1, B3, B4 and PIR-B in POCs and MOCs were constitutively tyrosine phosphorylated and were constitutively associated with SHP-1.
When POCs were stained doubly with Alexa546-conjugated LILRB mAb and Alexa647-conjugated HLA-A, B, C mAb, and then excited with the 532-nm laser, we detected a strong FRET effect from the excited LILRB1 mAb signal to the HLA-A, B, C mAb signal (7.5 ± 0.6%). As a positive control, β2-microglobulin showed a strong energy transfer with HLA-A, B, C (12.0 ± 1.2%). In contrast, negative control LILRB3 and B4 did not show a significant energy transfer with HLA-A, B, C on POCs (2.3 ± 0.4% and 3.5 ± 0.4%, respectively). These findings strongly suggest that LILRB1, but not LILRB3 or LILRB4, can associate with MHC class I in cis on POC surface. Also on murine POCs, FRET effect was clearly detected between PIR-B and H-2 Kb/Db as well as that between LILRB1 and HLA-A, B, C.
Discussion: LILRB1 and LILRB2 are human orthologs of murine PIR-B because of their similarity in their chromosomal localization, overall structure, and the ligand binding specificities. In this study, we demonstrated that human LILRB1, B3, B4 and murine PIR-B are expressed in cultured osteoclast precursor cells and these molecules could be inhibitory to osteoclast development in the presence of RANKL and M-CSF. We also showed that one of the inhibitory mechanisms could be the constitutive cis binding of LILRB1 and PIR-B to MHC class I molecules on the same osteoclast precursor cells, thus leading to the constitutive recruitment of SHP-1. A role of LILRB3 and B4 was also shown to be downmodulation of osteoclast development by associating with SHP-1 like LILRB1 does, but we could not analyze the possible mechanisms further under the lack of information on their ligands. This is the first report to demonstrate the regulation of osteoclast formation by the inhibitory immunoglobulin-like receptors. The inhibitiory signal via LILRB and PIR-B mediated by SHP-1 may play an important role in regulation of osteoclast development.
